JCO Precision Oncology

Published by: American Society of Clinical Oncology  

People

  1. Ladanyi
    Ladanyi
  2. Berger
    Berger
  3. Mandelker
    Mandelker
  4. Riely
    Riely
  5. Carlo
    Carlo
  6. Arcila
    Arcila
  7. Offit
    Offit
  8. Shukla
    Shukla
  9. Stadler
    Stadler
  10. Antonescu
    Antonescu

Groups

  1. Tow Center for Developmental Oncology (TCDO) (39)
  2. Department of Pathology and Laboratory Medicine (38)
  3. GSK Faculty (38)
  4. Human Oncology and Pathogenesis Program (35)
  5. Department of Medicine (31)
  6. Solid Tumor Oncology Division (31)
  7. Weinberg Fellows (22)
  8. Sloan Kettering Institute Postdocs (21)
  9. Center for Molecular Imaging and Biotechnology (CMIB) (19)
  10. Pediatrics, Department of (18)
Search Within
  1. "Tow Center for Developmental Oncology (TCDO) "
Formats
  1. Journal Article (38)
  2. Review (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (39)
  2. Department of Pathology and Laboratory Medicine (38)
  3. GSK Faculty (38)
  4. Human Oncology and Pathogenesis Program (35)
  5. Department of Medicine (31)
  6. Solid Tumor Oncology Division (31)

More Groups

People
  1. Marc Ladanyi (24)
  2. Ahmet Zehir (12)
  3. Michael Berger (12)
  4. Diana Mandelker (10)
  5. Gregory Riely (9)
  6. Michael Walsh (9)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (6)
  4. 2022 (7)
  5. 2021 (1)
  6. 2020 (4)

More Years

Publishers
  1. American Society of Clinical Oncology (39)

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical activity of mitogen-activated protein kinase inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers
    Review

    Dankner, M.; Rousselle, E.; Petrecca, S.; Fabi, F.; Nowakowski, A.; Lazaratos, A. M.; Vincent Rajadurai, C.; Stein, A. J. B.; Bian, D.; Tai, P.; more...
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Response to crizotinib after entrectinib resistance in ROS1-rearranged, MET-amplified lung adenocarcinoma
    Journal Article

    Vaz, V. R.; Gandhi, M. M.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Ladanyi, M.; Vanderbilt, C.; Pecci, F.; Aldea, M.; Barrichello, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Combination of MDM2 and targeted kinase inhibitors results in prolonged tumor control in lung adenocarcinomas with oncogenic tyrosine kinase drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Smith, R. S.; Vojnic, M.; Hayashi, T.; Khodos, I.; Markov, V.; Liu, Z.; Lui, A. J. W.; Bloom, J. L.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Modeling extraordinary response through targeting secondary alterations in fusion-associated sarcoma
    Journal Article

    Vanoli, F.; Song, E.; Dermawan, J. K.; Fishinevich, E.; Sung, P.; Min, S. S.; Xie, Z.; de Traux de Wardin, H.; Hwang, S.; Maki, R. G.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • NF1-driven rhabdomyosarcoma phenotypes: A comparative clinical and molecular study of NF1-mutant rhabdomyosarcoma and NF1-associated malignant triton tumor
    Journal Article

    de Traux de Wardin, H.; Dermawan, J. K.; Vanoli, F.; Jiang, S. C.; Singer, S.; Chi, P.; Tap, W.; Wexler, L. H.; Antonescu, C. R.
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Associations between cancer predisposition mutations and clonal hematopoiesis in patients with solid tumors
    Journal Article

    Franch-Expósito, S.; Mehine, M.; Ptashkin, R. N.; Bolton, K. L.; Bandlamudi, C.; Srinivasan, P.; Zhang, L.; Goodell, M. A.; Gedvilaite, E.; Menghrajani, K.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Germline pathogenic variants and genetic counseling by ancestry in patients with epithelial ovarian cancer
    Journal Article

    Sia, T. Y.; Maio, A.; Kemel, Y. M.; Arora, K. S.; Gordhandas, S. B.; Kahn, R. M.; Salo-Mullen, E. E.; Sheehan, M. A.; Tejada, P. R.; Bandlamudi, C.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic features of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer
    Journal Article

    Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Preeshagul, I.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Prevalence and clinical implications of mismatch repair-proficient colorectal cancer in patients with Lynch syndrome
    Journal Article

    Ranganathan, M.; Sacca, R. E.; Trottier, M.; Maio, A.; Kemel, Y.; Salo-Mullen, E.; Catchings, A.; Kane, S.; Wang, C.; Ravichandran, V.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Extremity rhabdomyosarcoma-An integrated clinicopathologic and genomic study to improve risk stratification
    Journal Article

    de Traux de Wardin, H.; Xu, B.; Dermawan, J. K.; Smith, M. H.; Wolden, S. L.; Antonescu, C. R.; Wexler, L. H.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save

    • JCO Precision Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 American Society of Clinical Oncology
    JCO Precision Oncology 24734284 Unknown
    Jco Precision Oncology Lippincott Williams & Wilkins
    Jco Precision Oncology American Society of Clinical Oncology
    Jco Precision Oncology American Society of Clinical Oncology
    JCO Precision Oncology 2473-4284 American Society of Clinical Oncology
    Unknown (24734284) 24734284 American Society of Clinical Oncology